NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03390504,A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations,https://clinicaltrials.gov/study/NCT03390504,THOR,ACTIVE_NOT_RECRUITING,"The purpose of this study is to evaluate efficacy of erdafitinib versus chemotherapy or pembrolizumab in participants with advanced urothelial cancer harboring selected fibroblast growth factor receptor (FGFR) aberrations who have progressed after 1 or 2 prior treatments, at least 1 of which includes an anti-programmed death ligand 1(PD-\[L\]1) agent (cohort 1) or 1 prior treatment not containing an anti-PD-(L) 1 agent (cohort 2).",NO,Urothelial Cancer,DRUG: Erdafitinib|DRUG: Vinflunine|DRUG: Docetaxel|DRUG: Pembrolizumab|DEVICE: Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA),"Overall Survival (OS), Overall survival is measured from the date of randomization to the date of the participant's death. If the participant is alive or the vital status is unknown, the participant will be censored at the date the participant was last known to be alive., Date of first randomization to the date of participant's death (approximately up to 3 years)","Progression-free Survival (PFS), PFS is defined as duration in days from date of randomization to disease progression date (assessed per Response Evaluation Criteria in Solid Tumors Version 1.1 \[RECIST v1.1\] by investigator) or relapse from CR or death, whichever is reported first. RECIST 1.1, progressive disease is defined as a 20 percent (%) increase in the sum of diameters of all target lesions and a minimum absolute increase of 5 millimeter (mm) in the sum. CR is defined as disappearance of all target lesions, non-target lesions and normalization of tumor marker level., Date of randomization to the date of disease progression or relapse from complete response (CR) or death, whichever is reported first (approximately up to 3 years)|Overall Response Rate (ORR), ORR is defined as the proportion of participants who achieve CR (CR; disappearance of all target lesions and disappearance of all non-target lesions and normalization of tumor marker level) or partial response (PR; at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters), as assessed per RECIST v1.1 by the investigator., Approximately up to 3 years|Change from Baseline in Participant-Reported Health Status and Physical Functioning Scales of the Functional Assessment of Cancer Therapy (FACT-Bl), The FACT-Bl consists of 36 core items, with 5-point Likert response scales, covering 5 primary domains: Physical well-being, social/family well-being, emotional well-being, functional well-being, and bladder symptom subscale. The answer scales range from ""Not at all (score=0)"" to ""very much (score=4)"" to assess the meaningful significant symptom deterioration., Baseline up to end of treatment (approximately 3 years)|Time Until Symptom Deterioration (Subset of FACT-BI Items), The FACT-Bl consists of 36 core items, with 5-point Likert response scales, covering 5 primary domains: Physical well-being, social/family well-being, emotional well-being, functional well-being, and bladder symptom subscale. The answer scales range from ""Not at all (score=0)"" to ""very much (score=4)"" to assess the meaningful significant symptom deterioration., Baseline up to end of treatment (approximately 3 years)|Change from Baseline in Patient-Global Impression of Severity (PGIS) Score, The PGIS is a single question regarding the participant report of disease severity. Participants will be asked that ''considering all aspects of your bladder cancer symptoms right now, would you say your bladder cancer symptoms are none, mild, moderate, severe, or very severe?"" The PGIS is an anchor question that will be used to establish the magnitude of meaningful change in this study by assessing disease severity., Baseline up to end of treatment (approximately 3 years)|Change from Baseline in the Visual Analog Scale (VAS) of the EQ-5D-5L, European Quality of Life 5 Dimensions (EQ-5D) visual analog scale (VAS) is a 20 centimeter (cm) vertical VAS with scores ranging from 0 (worst imaginable health) to 100 (perfect health). A higher score indicates an improvement in health in the Health Status Index., Baseline up to follow up phase (approximately 3 years)|Change from Baseline in the Utility Scale of the EQ-5D-5L, The EuroQol-5 is a five dimensional health state classification. Each dimension is assessed on a 3-point ordinal scale (1=no problems, 2=some problems, 3=extreme problems). The responses to the five EQ-5D dimensions were scored using a utility-weighted algorithm to derive an EQ-5D health status index score between 0 to 1, with 1.00 indicating ""full health"" and 0 representing dead., Baseline up to follow up phase (approximately 3 years)|Duration of Response (DOR), DOR for responders is defined as duration in days from the date of initial documentation of a response to the date of first documented evidence of progressive disease (PD) or relapse for participants who experience CR (CR; disappearance of all target lesions and disappearance of all non-target lesions and normalization of tumor marker level) during the study or death., From the date of initial documentation of a response to date of first documented evidence of progressive disease (or participants relapse who experience CR during the study) or death (approximately up to 3 years)|Number of Participants with Adverse Events (AEs) as a Measure of Safety, An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study., Approximately up to 3 years|Oral Clearance (CL/F) of Erdafitinib, CL/F is the oral clearance; that is clearance based on oral bioavailability of erdafitinib., Day 14 (Cycle 1), Day 1 (Cycle 2) (each cycle is of 21 days)|Area Under the Plasma Concentration-Time Curve from Time Zero to Time 't' (AUC[0-t]) of Erdafitinib, AUC(0-t) is the area under the plasma concentration-time curve from time zero to any time 't' of erdafitinib., Day 14 (Cycle 1), Day 1 (Cycle 2) (each cycle is of 21 days)",,"Janssen Research & Development, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,629,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CR108401|2017-002932-18|42756493BLC3001|2023-509329-32-00|2023-510296-56-00,2018-03-23,2023-01-15,2026-11-01,2018-01-04,,2025-03-25,"Alaska Urological Institute dba Alaska Clinical Research Center, Anchorage, Alaska, 99503, United States|University of Calif Davis Medical Center, Sacramento, California, 95817, United States|St. Helena Hospital - Martin-O'Neil Cancer Center, Saint Helena, California, 94574, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, 20007, United States|University of Miami Sylvester Cancer Center, Miami, Florida, 33136, United States|Mid Florida Hematology Oncology, Orange, Florida, 32763, United States|Piedmont Cancer Institute, Atlanta, Georgia, 30318-0922, United States|Rush University, Chicago, Illinois, 60612, United States|Edward Hines Jr V A Hospital, Hines, Illinois, 60141, United States|Norton Cancer Institute, Louisville, Kentucky, 40207, United States|Maryland Oncology Hematology, PA, Lanham, Maryland, 20706, United States|University of Michigan Health System, Ann Arbor, Michigan, 48109-5000, United States|VA Sierra Nevada Health Care System, Reno, Nevada, 89509, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Montefiore Medical Center, Bronx, New York, 10461, United States|Weill Cornell Medical College, New York, New York, 10029, United States|Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, 28204, United States|W G Bill Hefner VA Medical Center, Salisbury, North Carolina, 28144, United States|Oncology Hematology Care, Cincinnati, Ohio, 45242, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Texas Oncology-Memorial City, Houston, Texas, 77024, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology Tyler, Tyler, Texas, 75702, United States|INOVA Dwiight &Martha Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|VA Puget Sound Healthcare System, Seattle, Washington, 98108, United States|Sociedade Beneficente de Senhoras - Hospital Sírio Libanês, Buenos Aires, C1419AHN, Argentina|Centro Oncológico Korben, Buenos Aires, C1426AGE, Argentina|CEMIC Saavedra, Ciudad Autonoma de Buenos Aires, C1431FWN, Argentina|Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Cordoba, C5000, Argentina|Centro Urologico Profesor Bengio, Cordoba, X5000KPH, Argentina|Hospital Privado de Comunidad, Mar Del Plata, B7602CBM, Argentina|Centro de Investigacion Pergamino SA, Pergamino, B2700CPM, Argentina|Clínica Viedma, Viedma, R8500ACE, Argentina|Chris O'Brien Lifehouse, Camperdown, 2050, Australia|Peninsula & South Eastern Haematology and Oncology Group, Frankston, 3199, Australia|St George Hospital, Kogarah, 2217, Australia|Peter MacCallum Cancer Centre, Melbourne, 3000, Australia|Frankston Hospital, Melbourne, 3199, Australia|Fiona Stanley Hospital, Murdoch, 6150, Australia|LKH-Univ. Klinikum Graz, Graz, 8036, Austria|Ordensklinikum Linz GmbH Elisabethinen, Linz, 4020, Austria|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, 5020, Austria|Krankenhaus der Barmherzigen Brüder, Vienna, 1020, Austria|Medical University Vienna MUV, Vienna, A-1090, Austria|OLV Ziekenhuis Aalst, Aalst, 9300, Belgium|ZNA Middelheim, Antwerpen, 2020, Belgium|Cliniques Universitaires Saint Luc, Bruxelles, 1200, Belgium|Clinique Notre Dame de Grâce, Charleroi, 6000, Belgium|AZ Maria Middelares, Gent, 9000, Belgium|UZ Gent, Gent, 9000, Belgium|CHC MontLegia, Liege, 4000, Belgium|Sint-Augustinus AZ, Wilrijk, 2610, Belgium|CHU UCL Namur - Site Godinne, Yvoir, 5530, Belgium|Fundacao Pio XII, Barretos, 14784-400, Brazil|Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte, 30130-100, Brazil|Nucleo de Ensino e Pesquisa do Instituto Mario Penna, Belo Horizonte, 30380-472, Brazil|Instituto de Oncologia do Parana, Curitiba, 80530-010, Brazil|Liga Paranaense de Combate ao Cancer, Curitiba, 81520 060, Brazil|Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, Goiania, 74605-070, Brazil|Clínica de Neoplasias Litoral Ltda., Itajai, 88301-220, Brazil|Fundacao Doutor Amaral Carvalho, Jau, 17210 080, Brazil|Liga Norte Riograndense Contra O Cancer, Natal, 59075-740, Brazil|Hospital das Clinicas de Porto Alegre, Porto Alegre, 90035-903, Brazil|Hospital Nossa Senhora da Conceicao S A, Porto Alegre, 91350 200, Brazil|Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, 20231 050, Brazil|Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, 22250 905, Brazil|Hospital Sao Rafael, Salvador, 41253-190, Brazil|CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo Andre, 09060-650, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base, Sao Jose do Rio Preto, 15090-000, Brazil|Fundacao Antonio Prudente A C Camargo Cancer Center, Sao Paulo, 01509 900, Brazil|Instituto Brasileiro de Controle do Cancer - Sao Camilo Oncologia, Sao Paulo, 03102-002, Brazil|Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, 05652 900, Brazil|Instituto de Oncologia de Sorocaba Onco Clinicas Especializadas, Sorocaba, 18030-005, Brazil|Sociedade Beneficente de Senhoras - Hospital Sírio Libanês, São Paulo, 01308 901, Brazil|Instituto D Or de Pesquisa e Ensino IDOR, São Paulo, 04502-001, Brazil|UMHAT 'Dr. Georgi Stranski', EAD, Pleven, 5800, Bulgaria|Complex Oncology Center - Plovdiv EOOD, Plovdiv, 4004, Bulgaria|Multiprofile Hospital for Active Treatment 'Tokuda Hospital Sofia', Sofia, 1407, Bulgaria|UMHAT Sofia Med, Sofia, 1797, Bulgaria|Multiprofile Hospital for Active Treatment 'Sveta Marina' EAD, Varna, 9010, Bulgaria|BC Cancer Agency - Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada|Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Cancercare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, P7B 6V4, Canada|Princess Margaret Hospital- UHN, Toronto, Ontario, M5G 2M9, Canada|Saskatchewan Cancer Agency (SCA) - Allan Blair Cancer Centre, Regina, Saskatchewan, S4T 7T1, Canada|Cancer Hospital Chinese Academy of Medical Sciences, Beijing, 100021, China|Peking University First Hospital, Beijing, 100034, China|Beijing Friendship Hospital, Beijing, 100050, China|Peking University Third Hospital, Beijing, 100191, China|Beijing Hospital, Beijing, 100730, China|Peking Union Medical College Hospital, Beijing, 100730, China|The First Bethune Hospital of Jilin University, Changchun, 130021, China|Sichuan Provincial Peoples Hospital, Chengdu, 610000, China|Sichuan University Huaxi Hospital, Chengdu, 610041, China|Chongqing University Cancer Hospital, ChongQing, 400030, China|Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China|Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China|Guangzhou First Municipal People's Hospital, Guangzhou, 510180, China|Zhejiang Provincial People's Hospital, Hangzhou, 310014, China|Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, 310020, China|The First Affliated Hospital Of Nanchang University, Nanchang, 330006, China|Nanjing Drum Tower Hospital, Nanjing, 210008, China|Jiangsu Cancer Hospital, Nanjing, 210009, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, ShangHai, 200127, China|Huadong Hospital Affiliated to Fudan University, Shanghai, 200400, China|Shengjing Hospital Of China Medical University, Shenyang, 110004, China|Shenzhen university General Hospital, Shenzhen, 518055, China|First Affiliated Hospital Of Wenzhou Medical College, Wenzhou, 325000, China|The First Affiliated Hospital of Xian Jiaotong University, Xian, 710061, China|Institut de Cancerologie de l Ouest ICO, Angers, 49055, France|Hopital Jean Minjoz, Besancon Cedex, 25030, France|Institut Bergonie, Bordeaux, 33000, France|CHRU Brest - Hopital Morvan, Brest, 29609, France|Centre Jean Perrin, Clermont Ferrand, 63011, France|Centre Georges-François Leclerc, Dijon, 21079, France|Hôpital Privé Le Bois, Lille, 59000, France|Centre Oscar Lambret, Lille, 59020, France|Groupe Hospitalier Bretagne Sud, Lorient, 56322, France|Hopital de la Timone, Marseille, 13005, France|Institut Regional du Cancer de Montpellier Val d'Aurelle, Montpellier, 34298, France|Centre Antoine Lacassagne, Nice, 06189, France|Institut de Cancérologie du Gard, Nîmes, 30029, France|Hospital Saint-Louis, Paris Cedex 10, 75475, France|Hopital Europeen Georges-Pompidou, Paris, 75015, France|Hospices Civils de Lyon HCL, Pierre-Bénite, 69495, France|CHU De Poitiers, Poitiers Cedex, 86021, France|Centre Eugene Marquis, Rennes Cedex, 35062, France|Centre de radiothérapie et d'Oncologie médicale de l'Essonne, Ris Orangis, 91130, France|Institut de Cancérologie de Loire, Saint-Priest-en-Jarez, 42271, France|Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg Cedex, 67098, France|Institut Claudius Regaud, Toulouse, 31059, France|Centre Les Dentellieres, Valenciennes, 59300, France|Institut Gustave Roussy, Villejuif, 94805, France|Vivantes Klinikum Am Urban, Berlin, 10967, Germany|Stadtisches Klinikum Braunschweig gGmbH-Klinik fur Urologie und Uroonkologie, Braunschweig, 38126, Germany|Universitatsklinikum Carl Gustav Carcus Dresden, Dresden, 01307, Germany|Universitaetsklinikum Duesseldorf, Duesseldorf, 40225, Germany|Friedrich-Alexander Universitaet Urologische Universitaetskl, Erlangen, 91054, Germany|Universitatsklinikum Frankfurt, Frankfurt, 60590, Germany|Universitatsklinikum Freiburg, Freiburg, 79106, Germany|Universitätsmedizin Greifswald, Greifswald, 17475, Germany|Universitatsmedizin Gottingen, Göttingen, 37099, Germany|Asklepios Klinik Altona, Hamburg, 22763, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Universitatsklinikum Schleswig Holstein Campus Lubeck, Lubeck, 23538, Germany|Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, 68167, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|Studienpraxis Urologie Drs. Feyerabend, Nuertingen, 72622, Germany|Caritas-Krankenhaus St. Josef, Regensburg, 93053, Germany|Universitaetsmedizin Rostock, Rostock, 18057, Germany|MVZ-Onkologie Velbert GbR, Velbert, 42551, Germany|Kliniken Nordoberpfalz AG/Klinikum Weiden, Weiden, 92637, Germany|Errikos Dunant Hospital Center, Athens, 11526, Greece|Athens Medical Center, Athens, 15125, Greece|Metropolitan General A E, Athens, 15562, Greece|University of Athens Medical School - Regional General Hospi, Athina, 115 28, Greece|University Hospital Of Larissa, Larisa, 41110, Greece|University General Hospital of Rio Patras, Patras, 26504, Greece|Interbalkan European Medical Center, Thessaloniki, 14564, Greece|Euromedica General Clinic, Thessaloniki, 54645, Greece|Papageorgiou General Hospital Of Thessaloniki, Thessaloniki, 56403, Greece|Semmelweis Egyetem, Budapest, 1082, Hungary|Országos Onkológiai Intézet, Urogenitális Tumorok és Klinikai Farmakológiai Osztály, Budapest, 1122, Hungary|Budapesti Uzsoki Utcai Korhaz, Budapest, H-1145, Hungary|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza, 04400, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs, 7624, Hungary|Rambam Health Care Campus, Haifa, 31096, Israel|Hadassah Medical Center, Jerusalem, 91120, Israel|Meir Medical Center, Kfar Saba, 44281, Israel|Rabin Medical Center, Beilinson Hospital, Petach Tikvah, 49100, Israel|Sourasky Medical Center, Tel Aviv, 64239, Israel|The Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel|Assaf Harofeh Medical Center, Tzrifin, 70300, Israel|Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, 15121, Italy|Ospedale S. Donato - Asl 8 Arezzo, Arezzo, 52100, Italy|CRO IRCCS Istituto Nazionale Tumori, Aviano, 33081, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Presidio Spedali Civili, Brescia, 25123, Italy|Istituti Ospitalieri di Cremona, AO di Cremona, Cremona, 26100, Italy|Oncologia Medica, Firenze, 50139, Italy|SPDC Villa Scassi, Genova, Italy|UOC Oncologia Ospedale Provinciale di Macerata, Macerata, 62100, Italy|IRST Meldola Forli, Meldola, 47014, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, 20133, Italy|European Institute of Oncology, Milano, 20141, Italy|IRCCS Ospedale San Raffaele, Milan, 20132, Italy|AOU Policlinico di Modena, Modena, 41124, Italy|IRCCS-Fondazione Pascale, Napoli, 80131, Italy|Ospedale Maggiore della Carita, Novara, 28100, Italy|Aou San Luigi Gonzaga, Orbassano, 10043, Italy|Istituto Oncologico Veneto Iov Irccs Padova, Padova, 35128, Italy|AOU di Parma, Parma, 43126, Italy|IRCCS Policlinico San Matteo, Pavia, 27100, Italy|Ist. Clinici Scientifici Maugeri - Unità Operativa di Oncolo, Pavia, 27100, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, 56126, Italy|Usl 7 Siena - Ospedale Alta Valdelsa ASL TOSCANA SUD-EST, Poggibonsi (SI), 53100, Italy|Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, 00168, Italy|Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte, Siena, 53100, Italy|Oncologia Medica-Città Della Salute E Della Scienza Di Torino, Torino, 10123, Italy|Azienda Ospedaliero - Universitaria Ospedali Riuniti, Torrette Di Ancona, 60126, Italy|Chiba Cancer Center, Chiba, 260-8717, Japan|Hirosaki University Hospital, Hirosaki, 036-8563, Japan|National Cancer Center Hospital East, Kashiwa, 277 8577, Japan|Kagawa University Hospital, Kita Gun, 761 0793, Japan|Kobe City Medical Center General Hospital, Kobe, 650-0047, Japan|Dokkyo Medical University Saitama Medical Center, Koshigaya, 343-8555, Japan|Aso Co.,Ltd Iizuka Hospital, Matsuyama, 791-0280, Japan|University of Miyazaki Hospital, Miyazaki, 889-1692, Japan|Nagano Municipal Hospital, Nagano, 381-8551, Japan|Aichi Cancer Center Hospital, Nagoya Shi, 464 8681, Japan|Osaka International Cancer Institute, Osaka City, 541 8567, Japan|Kindai University Hospital, Osaka-Sayama, 589-8511, Japan|Osaka City University Hospital, Osaka, 545 8586, Japan|Gunma Prefectural Cancer Center, Ota, 373 8550, Japan|Kitasato University Hospital, Sagamihara, 252-0375, Japan|Toho University Sakura Medical Center, Sakura, 285-8741, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, 003-0804, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, 162-8666, Japan|Toranomon Hospital, Tokyo, 105-8470, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135 8550, Japan|University of Tsukuba Hospital, Tsukuba, 305 8576, Japan|Yamaguchi University Hospital, Ube, 755-8505, Japan|Yokohama City University Medical Center, Yokohama, 232 0024, Japan|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Chungnam National University Hospital, Daejeon, 35015, Korea, Republic of|National Cancer Center, Goyangsi, 410-769, Korea, Republic of|Chonnam National University Hospital, Gwangju, 61469, Korea, Republic of|Seoul National University Bundang Hospital, Gyeonggi-do, 13620, Korea, Republic of|Gachon University Gil Medical Center, Incheon, 21565, Korea, Republic of|Korea University Anam Hospital, Seoul, 02841, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, 03181, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, 03722, Korea, Republic of|Samsung Medical Center, Seoul, 135-710, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-si, 26426, Korea, Republic of|Medicos Especialistas en Cancer, S.C., Aguascalientes, 20230, Mexico|Centro Estatal de Cancerología de Chihuahua, Chihuahua, 31000, Mexico|Oncologia Integral Satelite, Naucalpan, 53100, Mexico|Antoni van Leeuwenhoek, Amsterdam, 1066 CX, Netherlands|Haga ziekenhuis, Den Haag, 2545 CH, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, 3430 EM, Netherlands|Centrum Onkologii im Prof F Lukaszczyka w Bydgoszczy, Bydgoszcz, 85 796, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie, Warszawa, 02-507, Poland|Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, 02-781, Poland|Uniwersytecki Szpital Kliniczny we Wroclawiu, Wroclaw, 50 556, Poland|Hospital Lusíadas, Lisboa, 1500-458, Portugal|H. Santa Maria - Centro Hospitalar de Lisboa Norte, Lisboa, 1649-035, Portugal|Uls Sao Jose - Hosp. Sto Antonio Dos Capuchos, Lisboa, G1R 2J6, Portugal|Champalimaud Foundation Champalimaud Centre, Lisbon, 1400-038, Portugal|Instituto Portugues de Oncologia, Porto, 4200072, Portugal|Altai Regional Oncology Dispensary, Barnaul, 656049, Russian Federation|Chelyabinsk Regional Clinical Center Of Oncology And Nuclear Medicine, Chelyabinsk, 454087, Russian Federation|Irkutsk Regional Oncology Dispensary, Irkutsk, 664035, Russian Federation|Ivanovo Regional Oncology Dispensary, Ivanovo, 153040, Russian Federation|Kostroma regional oncology dispensary, Kostroma, 156005, Russian Federation|Leningrad Regional Oncology Dispensary, Kuzmolovsky, 188663, Russian Federation|City Clinical Hospital n.a. D.D.Pletnev, Moscow, 105077, Russian Federation|FSBSI 'N. N. Blokhin Russian Cancer Research Center', Moscow, 115478, Russian Federation|Russian Scientific Center of Roentgenoradiology, Moscow, 117997, Russian Federation|I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation|Hertzen Oncology Research Institute, Moscow, 125284, Russian Federation|City Clinical Hospital #1, Nalchik, 360017, Russian Federation|Privolzhsky District Medical Center under the Federal Medico-Biological Agency, Nizhni Novgorod, 603109, Russian Federation|Clinical Oncology Dispensary, Omsk, 644013, Russian Federation|GBUZ of Stavropol region Pyatigorsk Oncological Dispensary, Pyatigorsk, 357502, Russian Federation|Private Medical Institution Euromedservice, Saint Petersburg, 196603, Russian Federation|Pavlov First Saint Petersburg State Medical University, Saint Petersburg, 197022, Russian Federation|LLC 'Strategic Medical Systems', Saint-Petersburg, 192148, Russian Federation|Clinical hopital n/a Petra velikogo, Saint-Petersburg, 195067, Russian Federation|FGBOU Vo Mordovian National Research State University N. A. N.P. Ogareva, Saransk, 430032, Russian Federation|Saratov State Medical University, Saratov, 410000, Russian Federation|LLC Uromed, Smolensk, 214031, Russian Federation|GBUZ Oncology Centre #2 of Healthcare Department of Krasno, Sochi, 354057, Russian Federation|Russian Scientific Center of Radiology and Surgical Technologies, St. Petersburg, 197758, Russian Federation|Saint-Petersburg Clinical Scientific And Practical Center For Special Types Of Medical Care, St.Petersburg, 197758, Russian Federation|Multifunctional clinical medical center 'Medical city', Tyumen, 625041, Russian Federation|Bashkiria State Medical University, Ufa, 450000, Russian Federation|Vologda Regional Oncological Dispensary, Vologda, 160012, Russian Federation|Hosp. Univ. Infanta Cristina, Badajoz, 06006, Spain|Institut Català D'Oncologia-Hospital Universitari Germans Trias I Pujol, Badalona, 08916, Spain|Hosp Clinic de Barcelona, Barcelona, 08036, Spain|Hosp. de La Santa Creu I Sant Pau, Barcelona, 08041, Spain|Hosp. San Pedro de Alcantara, Caceres, 10003, Spain|Hosp Reina Sofia, Córdoba, 14004, Spain|Hosp. Univ. Virgen de Las Nieves, Granada, 18014, Spain|Complejo Hospitalario de Jaen, Jaén, 23007, Spain|Hosp. Univ. Insular de Gran Canaria, Las Palmas de Gran Canaria, 35016, Spain|Hosp. Univ. Lucus Augusti, Lugo, 27003, Spain|Hosp. Univ. 12 de Octubre, Madrid, 28041, Spain|Hosp. Univ. La Paz, Madrid, 28046, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, 28220, Spain|ALTHAIA, Xarxa Assistencial Universitària de Manresa, Manresa, 08243, Spain|Hosp. de Navarra, Pamplona, 31008, Spain|Hosp. Virgen Macarena, Sevilla, 41009, Spain|Hosp. Virgen Del Rocio, Sevilla, 41013, Spain|Hosp. Gral. Univ. Valencia, Valencia, 46014, Spain|Hosp. Univ. I Politecni La Fe, Valencia, 46026, Spain|Hosp. Univ. Miguel Servet, Zaragoza, 50009, Spain|Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Chang Gung Medical Foundation, Niao-Sung Hsiang, 833, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|Chi Mei Medical Center Yong Kang, Tainan, 710, Taiwan|National Taiwan University Hospital, Taipei City, 10002, Taiwan|Mackay Memorial Hospital, Taipei, 10449, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Koo Foundation Sun Yat-Sen Cancer Center, Taipei, 11259, Taiwan|Chang-Gung Memorial Hospital, LinKou Branch, Taoyuan, 333, Taiwan|Baskent University Adana Practice and Research Center Kisla Health Campus, Adana, 01120, Turkey|Hacettepe University Medical Faculty, Ankara, 6100, Turkey|Bezmialem University Medical Faculty, Istanbul, 34093, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, 34098, Turkey|Bakirkoy Training and Research Hospital, Istanbul, 34147, Turkey|Medipol Mega University Hospital, Istanbul, 34214, Turkey|T C Saglik Bakanlıgi Goztepe Prof Dr Suleyman Yalcın Sehir Hastanesi, Istanbul, 34722, Turkey|Pendik Training and Research Hospital, Istanbul, 34890, Turkey|Ege University, Izmir, 35100, Turkey|Dokuz Eylul Universitesi Tip Fakultesi, Izmir, 35340, Turkey|Kocaeli University Medical Faculty, Kocaeli, Turkey|Inonu Universitesi Turgut Ozal Tip Merkezi, Ic Hastaliklari, Malatya, 44400, Turkey|MI Dnipropetrovsk Region Clinical Hospital n a I.I.Mechnikov, Dnipropetrovsk, 49005, Ukraine|Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council, Dnipro, 49100, Ukraine|Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4, Dnipro, 49102, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, 76008, Ukraine|Regional Medical Clinical Center for Urology and Nephrology named after V.I. Shapoval, Kharkiv, 61037, Ukraine|Municipal non-profit enterprise 'Regional Center of Oncology', Kharkiv, 61070, Ukraine|National Cancer Institute, Kyiv, 03022, Ukraine|State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center, Kyiv, 03115, Ukraine|Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital', Lviv, 79010, Ukraine|Transkarpathian Regional University Oncology Clinic, Uzhgorod, 88000, Ukraine|Podilskiy Regional Center of Oncology, Vinnitsa, 21029, Ukraine|Zaokod, Zaporizhzhia, 69040, Ukraine|Zaporizhzhia medical Academy of postgraduate education, Zaporizhzhia Regoinal Clinical Hospital, Zaporizhzhia, 69600, Ukraine|University Hospitals Bristol - Bristol Haematology & Oncolog, Bristol, BS2 8ED, United Kingdom|St Bartholomew's Hospital, London, EC1A 7BE, United Kingdom|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|Charing Cross Hospital, London, W6 8RF, United Kingdom|The Christie NHS Foundation Trust Christie Hospital, Manchester, M20 4BX, United Kingdom|Derriford Hospital-Department of Medical Oncology, Plymouth, PL6 8QH, United Kingdom|University of Sheffield, Sheffield, S10 2 RX, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Royal Marsden Hospital, Sutton, SM2 5NG, United Kingdom",
